Pérez-Olmeda M - Search Results

1

Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodríguez-Rosado R, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 2000 Nov-Dec;3(6):335-40. J Hum Virol. 2000. PMID: 11100914 Clinical Trial.

2

Long-term suppression of HIV replication in patients with sustained benefit on zidovudine monotherapy.

Gómez-Cano M, Soriano V, Pérez-Olmeda M, Machuca A, Rodríguez-Rosado R, Valencia E, Moreno V, Gutiérrez M, González-Lahoz J. Gómez-Cano M, et al. AIDS. 1998 May 28;12(8):964-6. AIDS. 1998. PMID: 9631158 No abstract available.

3

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.

Gómez-Cano M, Rubio A, Puig T, Pérez-Olmeda M, Ruiz L, Soriano V, Pineda JA, Zamora L, Xaus N, Clotet B, Leal M. Gómez-Cano M, et al. AIDS. 1998 Jun 18;12(9):1015-20. AIDS. 1998. PMID: 9662197

4

[The hepatitis C virus: after the track of the human immunodeficiency virus].

Pérez-Olmeda M, Rodríguez-Rosado R, García-Samaniego J, Soriano V. Pérez-Olmeda M, et al. Rev Clin Esp. 1999 Jan;199(1):5-7. Rev Clin Esp. 1999. PMID: 10089769 Review. Spanish. No abstract available.

5

CCR5 genotype and human immunodeficiency virus type 1 infection in perinatally exposed infants.

Villalba N, Pérez-Olmeda M, de José M, Hernández M, Sirera R, Español T, González-Molina A, Soriano V. Villalba N, et al. Eur J Clin Microbiol Infect Dis. 1999 May;18(5):389-91. doi: 10.1007/pl00015029. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10421054 No abstract available.

6

Usefulness of genotypic analysis of resistance to nucleoside analogues in the clinical setting.

Pérez-Olmeda M, Rodríguez-Rosado R, Gómez-Cano M, Briones C, Soriano V. Pérez-Olmeda M, et al. Eur J Clin Microbiol Infect Dis. 1999 Jun;18(6):448-9. doi: 10.1007/s100960050317. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10442426

7

Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral load.

Rubio A, Gómez-Cano M, Puig T, Leal M, Pérez-Olmeda M, Ruiz L, Clotet B, Rey C, Zamora L, Xaus N, Soriano V. Rubio A, et al. Antivir Ther. 1999;4(1):45-9. Antivir Ther. 1999. PMID: 10682128

8

Efficiency of drug resistance genotypic tests in specimens with low HIV viral load.

Gómez-Cano M, Rubio A, Ruiz L, Pérez-Olmeda M, Leal M, Clotet B, Soriano V. Gómez-Cano M, et al. Antivir Ther. 1999;4(2):123-4. Antivir Ther. 1999. PMID: 10682158

9

Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy.

Pérez-Olmeda M, García-Samaniego J, Soriano V. Pérez-Olmeda M, et al. AIDS. 2000 Jan 28;14(2):212. doi: 10.1097/00002030-200001280-00023. AIDS. 2000. PMID: 10708298 No abstract available.

10

Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.

Pérez-Olmeda M, González J, García-Samaniego J, Arribas JR, Peña JM, Soriano V. Pérez-Olmeda M, et al. J Acquir Immune Defic Syndr. 1999 Nov 1;22(3):308-9. doi: 10.1097/00126334-199911010-00014. J Acquir Immune Defic Syndr. 1999. PMID: 10770353 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters